Search Results - Jinxi Ding

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned surv... by Gang Fang, Zhipeng Pi, Yiping An, Xinxin Cao, Wei Li, Wei Li, Xiangjun Zhu, Jinxi Ding, Jinxi Ding

    Published in Frontiers in Pharmacology (2025-01-01)
    Get full text
    Article


  2. 2

    Analysis of affordability differences for rare diseases in China: a comparison across disease types and regions by Ye Chen, Xinyang Chen, Yi Deng, Jinxi Ding

    Published in International Journal for Equity in Health (2024-03-01)
    Get full text
    Article


  3. 3

    Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises’ R&D investment: a difference-in-differences analysis in China by Jiaming Li, Xinyue Zhang, Rui Wang, Keyao Cao, Luhui Wan, Xu Ren, Jinxi Ding, Jinxi Ding, Wei Li, Wei Li

    Published in Frontiers in Public Health (2024-07-01)
    Get full text
    Article


  4. 4

    From Imitation to Innovation: A Study of China’s Drug R&D and Relevant National Policies by Jinxi Ding, Yajiong Xue, Huigang Liang, Rong Shao, Yongfa Chen

    Get full text
    Article


  5. 5

    Cost-utility of aripiprazole once-monthly versus paliperidone palmitate once-monthly injectable for schizophrenia in China. by Yiping An, Gang Fang, Zhipeng Pi, Yumeng Zhang, Wei Li, Jinxi Ding

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  6. 6

    Cost-utility of aripiprazole once-monthly versus paliperidone palmitate once-monthly injectable for schizophrenia in China by Yiping An, Gang Fang, Zhipeng Pi, Yumeng Zhang, Wei Li, Jinxi Ding

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  7. 7

    Changes in antibiotic use associated with the National Centralized Drug Procurement policy in China from 2019 to 2023 by Fanyu Lin, Haoye Li, Siyuan Yao, Nannan Zhao, Keying Zhu, Jinxi Ding, Wei Li

    Published in Scientific Reports (2025-07-01)
    Get full text
    Article


  8. 8

    Mechanisms influencing generic drug substitution behavior under the national centralized drug procurement policy by Fanyu Lin, Haoye Li, Keying Zhu, YangXiaolong Wu, Qile Fan, Jinxi Ding, Wei Li

    Get full text
    Article


  9. 9

    The impacts of national centralized drug procurement policy on drug utilization of medical institutions: an empirical study in a county-level hospital in China by Haoye Li, Fanyu Lin, Rui Wang, Chenxuan Zhu, Keyao Cao, Yu Chen, Gang Fang, Jiaming Li, Jinxi Ding, Wei Li

    Published in BMC Health Services Research (2024-04-01)
    Get full text
    Article


Search Tools: